SCHEMBL328414

SCHEMBL328414

CN(CCN(CC(N)=O)S(=O)(=O)c1cc(F)c(Oc2ccc(Cl)cc2)c(F)c1)S(C)(=O)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAGLA Q9Y4D2 3/20 0.37
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA9 Q16790 1/20 0.34
POLB P06746 1/20 0.34
HPGD P15428 1/20 0.34
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34
BMP1 P13497 1/20 0.33
THRB P10828 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
MMP2 P08253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL328661 0.91 KMT2A (0.38) DAGLAKMT2AALDH1A1L3MBTL1CA12
SCHEMBL328548 0.91 DAGLA (0.37) DAGLAKMT2AALDH1A1L3MBTL1CA12
SCHEMBL6850484 0.89 DAGLA (0.36) DAGLAKMT2AALDH1A1L3MBTL1POLB
SCHEMBL328544 0.89 DAGLA (0.35) DAGLAKMT2AALDH1A1L3MBTL1CA12
SCHEMBL328649 0.89 MMP1 (0.44) KMT2ACA9BMP1MMP2MMP9
SCHEMBL6850664 0.87 DAGLA (0.43) DAGLAALDH1A1L3MBTL1POLBHPGD
SCHEMBL6852280 0.85 BDKRB1 (0.40) DAGLAKMT2AALDH1A1L3MBTL1CA12
SCHEMBL10066710 0.85 LSS (0.41) DAGLAKMT2AALDH1A1L3MBTL1CA12
SCHEMBL328643 0.84 KMT2A (0.35) DAGLAKMT2AALDH1A1POLBCYP3A4
SCHEMBL6850244 0.83 EDNRA (0.39) DAGLAL3MBTL1CYP2C19MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2428509-A1 Human adam-10 inhibitors Symphony Evolution, Inc. (US) 2012-03-14 EP disclosed
WO-2011011181-A1 PHARMACOLOGICAL CHAPERONES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AMICUS THERAPEUTICS, INC. (US) 2011-01-27 WO disclosed